Publication: Hormonalprofiles and prevalence of polycystic ovary syndrome in women with acne
1
Issued Date
1997-01-01
Resource Type
ISSN
03852407
Other identifier(s)
2-s2.0-0030611848
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Dermatology. Vol.24, No.4 (1997), 223-229
Suggested Citation
Penwadee Timpatanapong, Aram Rojanasakul Hormonalprofiles and prevalence of polycystic ovary syndrome in women with acne. Journal of Dermatology. Vol.24, No.4 (1997), 223-229. doi:10.1111/j.1346-8138.1997.tb02778.x Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/18175
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Hormonalprofiles and prevalence of polycystic ovary syndrome in women with acne
Author(s)
Other Contributor(s)
Abstract
One of the important etiologic factors in acne is an increase in sebaceous gland activity, which is androgen dependent. Acne is a common manifestation of hyperandrogenemia. Therefore, acne may not only cause cosmetic concern but may also be a sign of underlying disease. In females, the most common cause of hyperandrogenemia is polycystic ovary syndrome (PCOS). The purpose of this study was to determine the hormonal profiles of women with acne and the prevalence of PCOS in women attending the dermatological clinic with acne problems. The diagnostic criteria of PCOS were clinical findings of menstrual disturbances and hyperandrogenism (ache, seborrhea, hirsutism), pelvic ultrasound imaging of PCO (multiple subcapsular ovarian cysts 2-8 mm, in diameter, with dense echogenic stroma), and an elevated luteinizing hormone (LH) to follicle stimulating hormone (FSH) ratio. There were 51 women with acne; 20 regularly menstruating volunteers without ache served as a control group. PCOS was found in 19 out of 51 patients with acne (37.3%) anti none of the control group. Twenty acne patients had abnormal menstruation (39.2%). Ache cases had higher mean levels of serum total testosterone (T), free T, dehydroepiandrosterone sulfate (DHEAS) and prolactin (PRL). No statistically significant difference was observed for LH, FSH or sex hormone binding globulin (SHBG). Because of this high prevalence of PCOS in women with acne, all women presenting with ache should be asked about their menstrual pattern and examined for other signs of hyperandrogenemia. Hormonal profile determination as well as pelvic ultrasonography for ovarian visualization should be performed to confirm the diagnosis of PCOS in female acne patients who have menstrual disturbances.